(by Veronika Kyrylenko | The New American) – On January 31, the U.S. Food and Drug Administration (FDA), without convening its expert vaccine advisory panel, gave full approval to a Moderna COVID shot that will be marketed as Spikevax and used in people 18 and older. While the agency claims that the jab “meets the FDA’s rigorous standards for safety, effectiveness and manufacturing quality,” federal regulators removed the key documents that they used to reach that conclusion. According to The Epoch Times, the FDA document “Summary Basis for Regulatory Action,” which “explain[s] why the agency approved Moderna’s COVID-19 vaccine,” was “removed from the […]

This post was originally published on this site